SCOPUS 정보 검색 플랫폼

Volumn 27, Issue 7, 2000, Pages 691-

Monitoring response to treatment in the development of anticancer drugs using PET

Author keywords

Drug development; PET

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 11; FLUORODEOXYGLUCOSE F 18; THYMIDINE;

CANCER; CANCER CHEMOTHERAPY; DRUG UPTAKE; HUMAN; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; SHORT SURVEY; TREATMENT OUTCOME; TUMOR BLOOD FLOW;

EID: 0033736484 PISSN: 09698051 EISSN: None Source Type: Journal
DOI: 10.1016/S0969-8051(00)00140-2 Document Type: Article

Times cited : (4)

References (6)

1
- 0030022224
- The role of positron emission tomography within the spectrum of medical imaging
- (1996) Eur. J. Nucl. Med. , vol.23 , pp. 207-211
- Jones, T.¹

2
- 0002371016
- The use of radiolabelled anticancer drugs in Phase I/II clinical trials and the assessment of therapeutic efficacy of new agents using PET
- PET for Drug Development and Evaluation(Edited by Comar D.), Kluver Academic Publishers
- (1995) , pp. 301-326
- Price, P.¹ Harte, R.² Tilsley, O.³

3
- 0029564656
- Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group
- (1995) Eur. J. Cancer , vol.31 A , pp. 1924-1927
- Price, P.¹ Jones, T.²

5
- 0032757213
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations
- (1999) Eur. J. Cancer , vol.35 , Issue.13 , pp. 1773-1782
- Young, H.¹ Baum, R.² Cremerius, K.³ Herholz, K.⁴ Hoekstra, O.⁵ Lammertsma, A.A.⁶ Pruim, J.⁷ Price, P.⁸

6
- 0033003753
- Monitoring response to treatment in the development anti-cancer drugs using positron emission tomography (PET)
- (1999) Drug Information Journal , vol.33 , Issue.1 , pp. 237-244
- Young, H.¹ Brock, C.² Wells, P.³ Price, P.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.